HighTide Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	215.51	310.75	608.21	412.34	765.29
Short-Term Investments	-	0.18	0.68	428.26	0.5
Trading Asset Securities	230.06	179.77	127.49	-	-
Cash & Short-Term Investments	445.57	490.7	736.38	840.6	765.79
Cash Growth	-20.92%	-33.36%	-12.40%	9.77%	-
Other Receivables	0.56	10.9	16.31	2.34	3.64
Receivables	0.56	10.9	16.31	2.34	3.64
Other Current Assets	60.09	11.77	26.07	8.08	5.75
Total Current Assets	506.22	513.37	778.75	851.02	775.18
Property, Plant & Equipment	20.68	23.89	14.98	4.81	3.45
Long-Term Investments	-	21.09	-	-	-
Other Long-Term Assets	1.58	1.58	1.3	-	-
Total Assets	528.48	559.93	795.04	855.82	778.63
Accounts Payable	54.85	51.47	30.51	21.7	6.09
Accrued Expenses	-	5.34	40.68	23.55	14.75
Short-Term Debt	80.34	46.93	3.5	8.15	7
Current Portion of Long-Term Debt	-	-	-	1,260	-
Current Portion of Leases	6.08	5.49	2.47	1.11	0.25
Current Income Taxes Payable	-	0.3	0.38	0.31	0.23
Current Unearned Revenue	-	-	1.4	4.64	-
Other Current Liabilities	6.07	0.42	0.87	0.24	0.21
Total Current Liabilities	147.34	109.95	79.81	1,320	28.53
Long-Term Debt	-	9.96	-	-	1,006
Long-Term Leases	13.05	15.53	10.46	1.51	0.9
Long-Term Unearned Revenue	0.27	0.33	1.99	5.12	15.56
Total Liabilities	160.66	135.76	92.26	1,326	1,051
Common Stock	0.36	0.36	0.36	0.03	0.03
Additional Paid-In Capital	2,316	2,316	2,316	30.61	30.61
Retained Earnings	-2,198	-2,078	-1,696	-757.01	-566.77
Treasury Stock	-0.04	-0.04	-0.04	-0.01	-0
Comprehensive Income & Other	198.01	186.35	83.17	3.12	11.14
Total Common Equity	315.51	424.17	702.77	-723.26	-524.99
Shareholders' Equity	367.81	424.17	702.77	-470.53	-272.26
Total Liabilities & Equity	528.48	559.93	795.04	855.82	778.63
Total Debt	99.47	77.91	16.43	1,271	1,014
Net Cash (Debt)	346.09	412.8	719.94	-430.19	-248.27
Net Cash Growth	-35.95%	-42.66%	-	-	-
Net Cash Per Share	0.77	0.91	2.77	-1.69	-5.91
Filing Date Shares Outstanding	514.77	514.77	514.77	40.35	42.04
Total Common Shares Outstanding	514.77	514.77	514.77	40.35	42.04
Working Capital	358.88	403.43	698.94	-468.7	746.65
Book Value Per Share	0.61	0.82	1.37	-17.92	-12.49
Tangible Book Value	315.51	424.17	702.77	-723.26	-524.99
Tangible Book Value Per Share	0.61	0.82	1.37	-17.92	-12.49
Machinery	-	4.53	6.09	5.29	5.11
Leasehold Improvements	-	4.44	0.27	0.27	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.